Clinical Trial: Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Open Study of Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
Brief Summary: Use of oral clarithromycin for treatment of chronic lung disease due to Mycobacterium avium-intracellulare and other non-tuberculous Mycobacteria
Detailed Summary: Oral clarithromycin for treatment of MAC and other nontuberculous mycobacteria in adults with clinical history
Sponsor: The University of Texas Health Science Center at Tyler
Current Primary Outcome: Clinical and microbiological outcomes, such as clinical symptoms and laboratory cultures [ Time Frame: Monthly while on treatment, then followup after therapy discontinuation will be at one month, then at 3 months, then at 6 months, then annually, and prn for life ]
Original Primary Outcome: Clinical and microbiological outcomes, such as clinical symptoms and laboratory cultures [ Time Frame: Monthly while on treatment, then followup after therapy discontinuation will be at one month, then at 3 months, then at 6 months, then annually, and prn for life ]
Current Secondary Outcome: Microbiological cultures [ Time Frame: Monthly while on treatment, then followup after therapy discontinuation will be at one month, then at 3 months, then at 6 months, then annually, and prn for life ]
Original Secondary Outcome: Microbiological cultures [ Time Frame: Monthly while on treatment, then followup after therapy discontinuation will be at one month, then at 3 months, then at 6 months, then annually, and prn for life ]
Information By: The University of Texas Health Science Center at Tyler
Dates:
Date Received: January 14, 2008
Date Started: January 1991
Date Completion:
Last Updated: May 18, 2017
Last Verified: May 2017
